Vice President, Drug Safety and Pharmacovigilance

Annexon Biosciences(1 month ago)

HybridFull TimeExecutive$362,700 - $403,000Drug Safety & Pharmacovigilance

About this role

The Vice President, Drug Safety and Pharmacovigilance will lead Annexon’s drug safety function, overseeing patient safety across the company’s investigational compounds and clinical programs. The role involves building and managing the PV department, developing short- and long-term safety strategy, and representing pharmacovigilance with internal stakeholders and health authorities. The position reports to the SVP, Regulatory and is accountable for ensuring compliance with global safety regulations and protecting patient safety in trials.

View Original Listing

Required Skills

Pharmacovigilance
Signal Detection
Aggregate Reporting
Risk Management
Medical Review
Clinical Collaboration
Team Management
Regulatory Affairs
Safety Databases
GCP

+3 more

Qualifications

MD
MBBS
DO
Clinical Post-Training

About Annexon Biosciences

annexonbio.com

Annexon Biosciences is a biopharmaceutical company developing next‑generation complement therapies by targeting C1q, the initiating molecule of the classical complement pathway. By blocking C1q, Annexon aims to prevent downstream immune‑mediated damage in autoimmune, neurodegenerative (including Alzheimer’s and Huntington’s) and ophthalmic diseases affecting the body, brain, and eye. The company advances C1q‑targeted biologics through a pipeline of therapeutic candidates intended to provide disease‑modifying treatments for conditions driven by classical complement activation.